G1 THERAPEUTICS - 48 Year Dividend History | GTHX

Historical dividend payout and yield for G1 THERAPEUTICS (GTHX) since 1971. The current TTM dividend payout for G1 THERAPEUTICS (GTHX) as of June 14, 2019 is $0.00. The current dividend yield for G1 THERAPEUTICS as of June 14, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.696B $0.000B
G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It engaged in developing novel, small-molecule therapies which address significant unmet needs in the treatment of cancer. The company's product pipeline consists of CDK4/6, Trilaciclib (G1T28), G1T38 and G1T48. G1 Therapeutics, Inc. is based in Research Triangle Park, NC.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.397B 12.14
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.890B 53.83